Skmi.Bo

The company's capital structure is highly leveraged, with a debt-to-equity ratio of 2.73, significantly above the typical median for the specialty chemicals industry. Liquidity remains a concern, as the current ratio of 1.31 suggests limited short-term asset coverage over liabilities. Free cash flow of 19.7 million INR is positive but insufficient to cover long-term debt of 347.4 million INR.

Profitability metrics show a return on equity of 24.33%, which is strong, but return on assets of 5.73% is below the industry median for specialty chemicals. Operating income of 59.1 million INR represents 5.4% of revenue, indicating moderate operating margins. Gross profit of 227.2 million INR (20.9% of revenue) is in line with industry norms.

Geographic and segment exposure is not disclosed in the available data, but revenue concentration in a single jurisdiction or product line could increase operational risk. The company's business model appears to be focused on a core chemical production and distribution business.

Growth trajectory is unclear due to limited historical data, but the current FY outlook shows no directional guidance. The company reported negative operating cash flow of 90.2 million INR, which raises concerns about its ability to fund operations without external financing.

Risk factors include medium liquidity risk and a negative net cash position after subtracting total debt. Dilution risk is currently low, with no difference between basic and diluted shares outstanding. However, the company's reliance on long-term debt and negative operating cash flow could necessitate future equity or debt financing.

Recent filings and transcripts are not available in the source data, so no specific events can be cited to inform the company's recent strategic or operational developments.